UNITY BIOTECHNOLOGY INC - COM (UBX)

CUSIP: 91381U101

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
9,412,347
Share change
-3,206,886
Total reported value
$5,300,829
Put/Call ratio
3.4%
Price per share
$0.56
Number of holders
53
Value change
-$1,992,627
Number of buys
24
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q2 2022

As of 30 Jun 2022, UNITY BIOTECHNOLOGY INC - COM (UBX) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,412,347 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, GSA CAPITAL PARTNERS LLP, MARSHALL WACE, LLP, BAILLIE GIFFORD & CO, BlackRock Inc., Founders Fund V Management, LLC, ACADIAN ASSET MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 53 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.